Notochordal cells protect nucleus pulposus cells from degradation and apoptosis: implications for the mechanisms of intervertebral disc degeneration

Arthritis Research and Therapy

Volumn 13, Issue 6, 2011, Pages

  Erwin, W M ^a,c   Islam, Diana ^c   Inman, Robert D ^b,c   Fehlings, Michael G ^b,c,d   Tsui, Florence W L ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 1; CASPASE 3; CASPASE 8; CASPASE 9; CD44V ANTIGEN; COLLAGEN TYPE 2; FAS LIGAND; INTERLEUKIN 1BETA; INTERLEUKIN 6; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; ADAM PROTEIN; AGGRECAN; AGGRECANASE-1; CASPASE; HERMES ANTIGEN; LINK PROTEIN; PROCOLLAGEN N PROTEINASE; PROTEOGLYCAN; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CULTURE MEDIUM; FLOW CYTOMETRY; GENE EXPRESSION; INTERVERTEBRAL DISK DEGENERATION; MOLECULAR THERAPY; NONHUMAN; NOTOCHORD; NUCLEOTIDE SEQUENCE; NUCLEUS PULPOSUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CATTLE; CELL HYPOXIA; CYTOLOGY; DOG; DRUG EFFECT; GENETICS; INTERVERTEBRAL DISK; MALE; METABOLISM;

ADAM PROTEINS; AGGRECANS; ANIMALS; ANTIGENS, CD44; APOPTOSIS; CASPASES; CATTLE; CELL HYPOXIA; CELLS, CULTURED; COLLAGEN TYPE II; CULTURE MEDIA, CONDITIONED; DOGS; EXTRACELLULAR MATRIX PROTEINS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; MALE; MATRIX METALLOPROTEINASE 3; NOTOCHORD; PROCOLLAGEN N-ENDOPEPTIDASE; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84855169648     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3548     Document Type: Article

References (37)

1. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental conditions affecting six large U.S. employers in 1999. J Occup Environ Med 2003, 45:5-14. 10.1097/00043764-200301000-00007, 12553174.
2. Aguiar DJ, Johnson SL, Oegema TR. Notochordal cells interact with nucleus pulposus cells: regulation of proteoglycan synthesis. Exp Cell Res 1999, 246:129-137. 10.1006/excr.1998.4287, 9882522.
3. Oegema TR. The role of disc cell heterogeneity in determining disc biochemistry: a speculation. Biochem Soc Trans 2002, 30:839-844.
4. Erwin WM, Inman RD. Notochord cells regulate intervertebral disc chondrocyte proteoglycan production and cell proliferation. Spine 2006, 31:1094-1099. 10.1097/01.brs.0000216593.97157.dd, 16648742.
5. Erwin WM, Ashman K, O'Donnell P, Inman RD. Nucleus pulposus notochord cells secrete connective tissue growth factor and upregulate proteoglycan expression by intervertebral disc chondrocytes. Arthritis Rheum 2006, 54:3859-3867. 10.1002/art.22258, 17136753.
6. Nesrin O, El-Deiry Wafik S. Defining characteristics of types I and II apoptotic cells in response to TRAIL. Neoplasia 2002, 4:551-557. 10.1038/sj.neo.7900270, 1503670, 12407450.
7. Krammer Peter H. CD95's deadly mission in the immune system. Nature 2000, 407:789-795. 10.1038/35037728, 11048730.
8. Yin X-M, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA, Korsmeyer SJ. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999, 400:886-891. 10.1038/23730, 10476969.
9. Jong-Beom P, Jin-Kyung L, Sung-Jin P, Ki-Won K, Riew KD. Mitochondrial involvement in Fas-mediated apoptosis in human lumbar disc cells. J Bone Joint Surg 2005, 87-A:1338-1342.
10. Hengartner MO. The Biochemistry of Apoptosis. Nature 2000, 407:770-776. 10.1038/35037710, 11048727.
11. Le Maitre C, Pockert A, Buttle DA, Freemont AJ, Hoyland JA. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans 2007, 35:652-655. 10.1042/BST0350652, 17635113.
12. Skubutyte R, Markova D, Freeman TA, Anderson GD, Dion AS, Williams CJ, Shapiro IM, Risbud MV. Hypoxia-inducible factor regulation of ANK expression in nucleus pulposus cells: possible implications in controlling dystrophic mineralization in the intervertebral disc. Arthritis Rheum 2010, 62:2707-2715. 10.1002/art.27558, 3065237, 20496369.
13. Hornebeck W. Down-regulation of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in aged skin contributes to matrix degradation and impaired cell growth and survival. Pathol Biol (Paris) 2003, 51:569-573.
14. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005, 7:R732-45. Epub, 10.1186/ar1732, 1175026, 15987475.
15. Cui LY, SL L, Ding Y, Huang DS, Ma RF, Huang WG, Hu BS, Pan QH. IL-1 beta sensitizes rat intervertebral disc cells to Fas ligand mediated apoptosis in vitro. Acta Pharmacol Sin 2007, 28:1671-1676. 10.1111/j.1745-7254.2007.00642.x, 17883956.
16. Cailotto F, Sebillaud S, Netter P, Jouzeau JY, Bianchi A. The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocytes. J Biol Chem 2010, 285:10572-10582. 10.1074/jbc.M109.050534, 2856265, 20133941.
17. Urban JP. The role of the physicochemical environment in determining disc cell behaviour. Biochem Soc Trans 2002, 30:858-864.
18. Urban JP, Smith S, Fairbank JC. Nutrition of the intervertebral disc. Spine 2004, 29:2700-2709. 10.1097/01.brs.0000146499.97948.52, 15564919.
19. Shirazi-Adl A, Taheri M, Urban JP. Analysis of cell viability in intervertebral disc: effect of endplate permeability on cell population. J Biomech 2010, 43:1330-1336. 10.1016/j.jbiomech.2010.01.023, 20167323.
20. Erwin WM, Las Heras F, Islam D, Fehlings MG, Inman RD. The regenerative capacity of the notochordal cell: tissue constructs generated in vitro under hypoxic conditions. J Neurosurg Spine 2009, 10:513-522. 10.3171/2009.2.SPINE08578, 19558283.
21. Fitzgerald JB, Jin M, Grodzinsky AJ. Shear and compression differentially regulate clusters of functionally-related temporal transcription patterns in cartilage tissue-supplemental material. J Biol Chem 2006, 281:24095-24103. 10.1074/jbc.M510858200, 16782710.
22. Nomura S, Yamaguchi MO, Wang TC, Lee JR, Goldenring JR. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol 2005, 288:362-375.
23. Le Maitre CL, Hoyland JA, Freemont AJ. Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res Ther 2007, 9:R77. 10.1186/ar2275, 2206382, 17688691.
24. Pockert AJ, Richardson SM, Le Maitre CL, Lyon M, Deaking JA, Buttle DA, Freemont AJ, Hoyland JA. Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis Rheum 2009, 60:482-491. 10.1002/art.24291, 19180493.
25. Patwari P, Gao G, Lee JH, Grodzinsky AJ, Sandy JD. Analysis of ADAMTS4 and MTW-MMP indicates that both are involved in aggrecanolysis in interleukin-1 treated bovine cartilage. Osteoarthritis Cartilage 2005, 13:269-277. 10.1016/j.joca.2004.10.023, 2771540, 15780640.
26. Karsdal MA, Madsen SH, Christiansen C, Henriksen K, Fosang AJ, Sondergaard BC. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther 2008, 10:R63. 10.1186/ar2434, 2483454, 18513402.
27. Sawaji Y, Hynes J, Vincent T, Saklatvala J. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum 2008, 58:3498-3509. 10.1002/art.24025, 18975307.
28. Gurley KA, Reimer RJ, Kingsley DM. Biochemical and genetic analysis of ANK in arthritis and bone disease. Am J Hum Genet 2006, 79:1017-1029. 10.1086/509881, 1698704, 17186460.
29. Hoyland JA, Le Maitre CA, Freemont AJ. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology 2008, 47:809-814. 10.1093/rheumatology/ken056, 18397957.
30. Park JB, Park IC, Park SJ, Jin HO, Lee JK, KD R. Anti-apoptotic effects of caspase inhibitors on rat intervertebral discs. J Bone Joint Surg Am 2006, 88:771-779.
31. Burke JG, Watson RWG, McCormack D, Dowling FE, Walsh MG, JM F. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002, 84:196-201. 10.1302/0301-620X.84B2.12511, 11924650.
32. Kang JD, Stefanovic-Racic M, Mcintyre LA, Georgescu H, Evans H. Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine 1997, 22:1065-1073. 10.1097/00007632-199705150-00003, 9160463.
33. Studer RK, Gilbertson LG, Georgescu H, Sowa G, Vo N, Kang JD. p38MAPK inhibition modulates rabbit nucleus pulposus cell response to Il-1. J Orthop Res 2008, 26:991-998. 10.1002/jor.20604, 18302237.
34. Donohue PJ, Jahnke MR, Blaha JD, Caterson B. Characterization of link protein(s) from human intervertebral disc tissues. Bioch J 1988, 251:739-747.
35. Pearce RH, Mathieson JM, Mort JS, Roughley P. Effect of age on the abundance and fragmentation of link protein of the human intervertebral disc. J Orthop Res 1989, 7:861-867. 10.1002/jor.1100070612, 2795326.
36. Kim HJ, Minashima T, McCarthy EF, Winkles JA, Kirsch T. Progressive ankylosis protein [ANK] in osteoblasts and osteoclasts control bone formation and bone remodeling. J Bone Miner Res 2010, 25:1771-1783. 10.1002/jbmr.60, 3153348, 20200976.
37. Schimmer AD, Dalili S, Batey RA, Riedl SJ. Targeting XIAP for the treatment of malignancy. Cell Death Differ 2006, 13:179-188. 10.1038/sj.cdd.4401826, 16322751.